Jennifer A. Sealey-Voyksner
Directeur Technique/Scientifique/R&D chez ENTERO THERAPEUTICS, INC.
Profil
Jennifer A.
Sealey-Voyksner is the founder of ImmunogenX, Inc., a company founded in 2013.
She held the title of Director & Chief Scientific Officer from 2013 to 2024.
Currently, Dr. Sealey-Voyksner is the Vice President-Research & Development at First Wave Biopharma, Inc., starting in 2024.
Postes actifs de Jennifer A. Sealey-Voyksner
| Sociétés | Poste | Début |
|---|---|---|
| ENTERO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 13/03/2024 |
Anciens postes connus de Jennifer A. Sealey-Voyksner
| Sociétés | Poste | Fin |
|---|---|---|
ImmunogenX LLC
 ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Fondateur | 13/03/2024 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ENTERO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ImmunogenX LLC
ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Health Technology |